Focus Partners Wealth’s VanEck Biotech ETF BBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$229K Buy
+936
New +$209K ﹤0.01% 2513
2025
Q1
– Sell
-1,729
Closed -$271K – 1912
2024
Q4
$271K Buy
+1,729
New +$291K ﹤0.01% 1596
2024
Q3
– Sell
-1,699
Closed -$299K – 1581
2024
Q2
$299K Buy
1,699
+404
+31% +$66.1K ﹤0.01% 1072
2024
Q1
$205K Buy
+1,295
New +$214K ﹤0.01% 932

Other funds holding BBH

Focus Partners Wealth's BBH Position: Q3 2026 in Review

Focus Partners Wealth opened a new position in VanEck Biotech ETF (BBH) in Q3 2026: 936 shares worth $229K. The stake represents ﹤0.01% of the portfolio and ranks #2513 among its holdings. This is a return to the name: Focus Partners Wealth previously reported a position in BBH as recently as Q4 2024.

Focus Partners Wealth first reported a position in BBH in Q1 2024 and has held it in 4 quarters since. The position peaked at $299K in Q2 2024. 122 funds tracked by Wall St. Rank hold BBH as of Q3 2026.

  • Focus Partners Wealth held 936 shares of VanEck Biotech ETF worth $229K as of Q3 2026.
  • VanEck Biotech ETF was a new Focus Partners Wealth position in Q3 2026.
  • VanEck Biotech ETF made up ﹤0.01% of Focus Partners Wealth's portfolio in Q3 2026, its #2513 holding.
  • Focus Partners Wealth first reported a position in VanEck Biotech ETF in Q1 2024 and has held it in 4 quarters since.
  • Focus Partners Wealth's VanEck Biotech ETF position peaked at $299K in Q2 2024.
  • 122 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q3 2026.

Based on Focus Partners Wealth's 13F filing for Q3 2026, filed 12 Nov 2026.